News Archives - Page 126 of 1183 - BioHealth Innovation

Puzzle pieces with word change 2021 08 26 22 35 29 utc

News

September 16, 2022

The Venture Capital Landscape Is Changing, and Perhaps Not for the Better | Maryland Smith

Startup companies have traditionally looked for the most experienced venture capitalists they could find to get their businesses off the…

admin

Love0

News

September 16, 2022

The University of Maryland Medical System is investing $14M in statewide economic development – Technical.ly

One of Maryland’s premiere medical networks just announced an eight-figure investment into the economic development of local and marginalized communities…

admin

Love0

News

September 16, 2022

Virginia’s AMPEL BioSolutions New Breakthrough Test Detects and Predicts Severity of COVID-19

CHARLOTTESVILLE, Va., Sept. 15, 2022 /PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the…

admin

Love0

News

September 15, 2022

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Waltham, Mass. and Dublin – August 15, 2022 — Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon…

admin

Love0

News

September 15, 2022

Streck Announces Series B Investment in Virginia’s Ceres Nanosciences

La Vista, Nebraska — September 14, 2022 – Streck announced today a Series B investment in Ceres Nanosciences (Ceres). The…

admin

Love0

News

September 15, 2022

Swimming With Sharks

Swimming with Sharks pairs aspiring healthcare entrepreneurs with successful innovators and investors. The startups selected will pitch at the American…

admin

Love0

News

September 15, 2022

Maryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures | MSCRF

September 13, 2022—The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that…

admin

Love0

News

September 13, 2022

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

- The Company plans to work with the FDA to design a Phase 3 program in moderate-to-high systemic disease activity patients to…

admin

Love0

Scientist in lab 2022 03 30 20 23 32 utc

News

September 13, 2022

Biden Spurs U.S. Biotechnology with New Order – Nextgov

The Biden administration announced the launch of a new national program dedicated to fortifying America’s biotechnology manufacturing industry in the…

admin

Love0

News

September 13, 2022

Qiagen joins monkeypox test-making efforts

As the number of monkeypox cases around the world has ballooned since early May, so too has the list of…

admin

Love0

News

The Venture Capital Landscape Is Changing, and Perhaps Not for the Better | Maryland Smith

The University of Maryland Medical System is investing $14M in statewide economic development – Technical.ly

Virginia’s AMPEL BioSolutions New Breakthrough Test Detects and Predicts Severity of COVID-19

Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases

Streck Announces Series B Investment in Virginia’s Ceres Nanosciences

Swimming With Sharks

Maryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures | MSCRF

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint

Biden Spurs U.S. Biotechnology with New Order – Nextgov

Qiagen joins monkeypox test-making efforts

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search